Two Uncomplicated Pregnancies on Alectinib in a Woman With Metastatic ALK-Rearranged NSCLC: A Case Report

Two Uncomplicated Pregnancies on Alectinib in a Woman With Metastatic ALK-Rearranged NSCLC: A Case Report

Lung cancer incidence is increasing in pregnancy due in part to advanced maternal age. A subset of patients with NSCLC during pregnancy harbor an ALK gene rearrangement. Although ALK inhibitors, such as alectinib, are routinely used to treat ALK-rearranged NSCLC, there are limited safety data regard...

Full description

Bibliographic Details
Main Authors: Chloe Weidenbaum, DO, Christopher G. Cann, MD, Sarah Osmundson, MD, MS, Wade T. Iams, MD, MSCI, Travis Osterman, DO, MS
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:JTO Clinical and Research Reports
Subjects:
ALK-rearranged non–small cell lung cancer
Pregnancy
Case report
Alectinib
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364322000856

Internet

http://www.sciencedirect.com/science/article/pii/S2666364322000856

Similar Items